IHI is an exchange-traded fund — it holds a basket of underlying assets rather than being a single operating company.
Company fundamentals like P/E, revenue, EPS and profit margins don't apply to a fund — its value comes from the assets it holds, not its own earnings. Use the price chart, options and model forecast below for fund-level analysis.
An institutional-grade, numbers-driven thesis on IHI — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of August 18, 2026, TradersQuant's model rates iShares U.S. Medical Devices ETF (IHI) 54/100 with a 12-month base-case forecast of $54.82 — -1.7% versus the current price of $55.76. iShares U.S. Medical Devices ETF trades at $55.76 in the Financial Services sector, with a market capitalisation of $3.11B. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month TradersQuant model price target for IHI is $54.82, implying -1.7% versus the current price. The model's 12-month scenario range runs from $48.36 (bear) to $64.46 (bull), with a base case of $54.82.
IHI currently carries a TradersQuant composite score of 54/100, which we read as a neutral-to-watch signal. Our 12-month price target of $54.82 implies -1.7% from $55.76. This is research, not financial advice — always combine it with your own judgement.
The TradersQuant 12-month model price target for IHI is $54.82, about -1.7% versus the latest price of $55.76.
TradersQuant's 12-month model forecast for IHI is a base case of $54.82, ranging from $48.36 (bear) to $64.46 (bull), an expected return of -1.7%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for IHI over the next 12 months is $54.82 in the base case (bear $48.36, bull $64.46), versus today's price of $55.76. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for IHI — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates IHI's fair value at $70.84, implying +27.1% of expected upside versus the current price.
iShares U.S. Medical Devices ETF does not currently pay a dividend.
Data and model outputs are for research only and are not financial advice. Figures update continuously.
